| Financial Year |
March 31 2023 |
| Monetary Funds |
208,999,516.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,142,000.74 |
| Accounts Receivable |
98,980,635.25 |
| Advances to Suppliers |
28,878,692.13 |
| Other Receivables |
737,181.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
75,252,144.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
245,123,284.57 |
| Total Current Assets |
666,236,339.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
5,790,674.16 |
| Investment Properties |
-- |
| Fixed Assetes |
48,472,206.95 |
| Under-construction Projects |
285,634,104.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
48,476,475.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,441,775.30 |
| Deferred Income Tax Assets |
2,446,743.44 |
| Other Non-Current Assets |
160,431,619.37 |
| Sub-Total of Non-Current Assets |
560,693,599.27 |
| Total Assets |
1,226,929,938.90 |
| Short-Term Loans |
28,793,400.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,300,679.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,503,893.87 |
| Taxes Payable |
2,503,588.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,379,541.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
500,000.00 |
| Other Current Liabilities |
3,242,410.18 |
| Sub-Total of Current Liabilities |
53,488,286.71 |
| Long-term Loans |
27,410,000.00 |
| Bonds Payable |
231,117,240.62 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,573,268.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
273,813,899.99 |
| Total Liabilities |
327,302,186.70 |
| Paid-In Capital(Or Share Stock) |
96,000,000.00 |
| Capital Surplus |
454,769,357.88 |
| Surplus Reserve |
38,186,486.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
249,484,554.00 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
899,627,752.20 |
| Owner's Equity（Stockholder's Equity） |
899,627,752.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,226,929,938.90 |
